Showing results (111-120 of 140) with videos related to

Sort By:
Pageof 14
Computational and Structural Biotechnology Journal|February 15, 2024
Enhancing Mass spectrometry-based tumor immunopeptide identification: machine learning filter leveraging HLA binding affinity, aliphatic index and retention time deviationFeifei Wei, Taku Kouro, Yuko Nakamura, et al.
Cancer Science|February 9, 2017
Immunological evaluation of peptide vaccination for cancer patients with the HLA -A11<sup>+</sup> or -A33<sup>+</sup> alleleShinjiro Sakamoto, Satoko Matsueda, Shinzo Takamori, et al.
International Journal of Cancer|October 12, 2018
Association between soluble immune mediators and tumor responses in patients with nonsmall cell lung cancer treated with anti-PD-1 inhibitorNorikazu Matsuo, Koichi Azuma, Satoshi Hattori, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|May 13, 2010
Graft-versus-leukemia antigen CML66 elicits coordinated B-cell and T-cell immunity after donor lymphocyte infusionWandi Zhang, Jaewon Choi, Wanyong Zeng, et al.
Frontiers in Immunology|December 30, 2024
Multi-omics analysis-based clinical and functional significance of a novel prognostic and immunotherapeutic gene signature derived from amino acid metabolism pathways in lung adenocarcinomaHuihui Xiang, Rika Kasajima, Koichi Azuma, et al.
Oncoimmunology|November 22, 2012
Detecting T-cell reactivity to whole cell vaccines: Proof of concept analysis of T-cell response to K562 cell antigens in CML patientsAna Brusic, Ursula Hainz, Martha Wadleigh, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|November 20, 2015
An Open-Label, Randomized Phase II Trial of Personalized Peptide Vaccination in Patients with Bladder Cancer that Progressed after Platinum-Based ChemotherapyMasanori Noguchi, Kazumasa Matsumoto, Hirotsugu Uemura, et al.
Cancer Immunology Research|October 30, 2014
Phase II study of personalized peptide vaccination for previously treated advanced colorectal cancerShiro Kibe, Shigeru Yutani, Satoru Motoyama, et al.
Frontiers in Cell and Developmental Biology|March 12, 2024
Circulating IL-6 and not its circulating signaling components sIL-6R and sgp130 demonstrate clinical significance in NSCLC patients treated with immune checkpoint inhibitorsYoshiro Nakahara, Taku Kouro, Satoru Motoyama, et al.
In Vivo (Athens, Greece)|March 1, 2020
Distribution of Regulatory T-Cells and Other Phenotypes of T-Cells in Tumors and Regional Lymph Nodes of Colorectal Cancer PatientsKeisuke Kazama, Junya Otake, Tetsuta Satoyoshi, et al.
Pageof 14